3Nguyen HB, Smith D. Sepsis in the 21st century:recent definitions and therapeutic advances [J]. Am J EmergMed, 2007, 25(5): 564-571.
4Esper AM, Martin GS. Extending international sepsis epidemiology: the impact of organ dysfunction[J]. Crit Care, 2009, 13(1): 120.
5Krishnagopalan S, Kumar A, Parrillo JE, et al. Myocardial dysfunction in the patient with sepsis [J]. Curr Opin Crit Care, 2002, 8(5): 376-388.
6Nduka OO, Parrillo JE. The pathophysiology of septic shock[J]. CritCareClin, 2009, 25(4): 677-702.
7Zink W, Kaess M, Hofer S, et al. Alterations in intracellular Ca2+-homeostasis of skeletal muscle fibers during sepsis[J]. Crit Care Med, 2008, 36(5): 1559- 1563.
8De Cruz S J, Kenyon N J, Sandrock CE. Bench-to- bedside review: the role of nitric oxide in sepsis [J]. Expert Rev Respir Med, 2009, 3(5): 511-521.
9OberholzerA, SouzaSM, TschoekeSK, etal. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis[J]. Shock, 2005, 23(6): 488-493.
10Post F, Weilemann LS, MessowCM, etal. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients[J]. Crit Care Med, 2008, 36(11): 3030-3037.
